TP53 and neoplasm: Cholesterol- or siRNA-resulted SQLE reduction could dissociate the interaction of GSK-3β and p53, leading to GSK-3β inhibition and p53 degradation, thereby accelerating the malignant conversion and invasiveness of tumor cells by the induction of the epithelial–mesenchymal transition [113].